最新公告:

  没有公告

您现在的位置: 心灵之窗-眼科医生网 >> 眼科常识 >> 第10届全国会 >> 眼底病10 >> 正文
专题栏目
更多内容
相关文章
更多内容
The applications of 25-gauge transconjunctival sutureless vitrectomy system in removal of epiretinal membranes of silicone oil-filled eyes         
The applications of 25-gauge transconjunctival sutureless vitrectomy system in removal of epiretinal membranes of silicone oil-filled eyes
作者:马 进 姜… 文章来源:浙江大学医学院附属二院眼科中心 点击数:1226 更新时间:2005/6/11 12:21:11
Purpose: To determine whether epiretinal membrane peeling in silicone oil-filled eyes can be safely performed by 25-gauge transconjunctival sutureless vitrectomy system (TSV). Design: A retrospective noncomparative interventional study. Methods: A prospective series of epiretinal membranes peeling in 19 silicone oil-filled eyes were performed using the 25-gauge TSV. The operating times at each of the steps of the operations were measured. The condition of leakage of silicone oil in puncture site was recorded. Follow-up ranged from 4 to 7.5 months. The visual acuity and intraocular pressures were measured preoperatively and postoperatively. The postoperative intraocular inflammatory response and observed intra-operative and post-operative complications were recorded. Results: No patients enlarge the sclerotomy, and no patients required conventional scleral sutures, without ongoing leakage of silicone oil. The mean pre-operative IOP was 23.6 mmHg (range 15-31mmHg). The mean IOP on post-operative day 1 was 24.1mmHg (range 12-33mmHg). The mean IOP one week after surgery was 20.3 mmHg (range 13-30.0 mmHg). No surgical complications related to the TSV25 system were observed. There was a noticeable decrease in the amount of post-operative inflammation. The patients reported a noticeable decrease in post-operative discomfort following surgery with the TSV25 system. Epiretinal membranes in all the eyes were removed successfully. Conclusion:Tranconjunctival vitrectomy using the TSV25 system can be safely and effectively performed without conventional scleral and conjunctival sutures, Which can minimize post-operative inflammation and patient discomfort.
会议投稿录入:majin    责任编辑:毛进 
  • 上一篇会议投稿:

  • 下一篇会议投稿:
  • 【字体: 】【发表评论】【加入收藏】【告诉好友】【打印此文】【关闭窗口
      网友评论:(只显示最新10条。评论内容只代表网友观点,与本站立场无关!)

    | 设为首页 | 加入收藏 | 联系站长 | 友情链接 | 版权申明 |
    眼科医生网 眼科医生网版权所有 @ 1998-2012
    部分文章和资源来源于网络,如果侵犯了您的版权,请指出! 站长:毛进
    信息产业部备案
    *京ICP备18030162号